762233-62-5 Usage
Uses
Used in Pharmaceutical Industry:
Pyrrolo[3,4-c]pyrazole, 1,4,5,6-tetrahydro-1-methyl(9CI) is used as a potential candidate for the development of new drugs due to its unique structure and potential biological activity. Its heterocyclic nature and the presence of a methyl group may contribute to its pharmacological properties, making it a promising compound for further research and development.
Used in Organic Synthesis:
Pyrrolo[3,4-c]pyrazole, 1,4,5,6-tetrahydro-1-methyl(9CI) is also being studied for its potential role in organic synthesis. Its specific structural features may allow it to serve as a building block or intermediate in the creation of new chemical compounds with tailored properties for various applications.
Used in Chemical Compound Design:
Furthermore, Pyrrolo[3,4-c]pyrazole, 1,4,5,6-tetrahydro-1-methyl(9CI) is being explored for its potential as a building block in the design of new chemical compounds with specific properties. Its unique ring structure and substituents may enable the development of novel materials with applications in various fields, pending further research and understanding of its properties.
Check Digit Verification of cas no
The CAS Registry Mumber 762233-62-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,2,2,3 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 762233-62:
(8*7)+(7*6)+(6*2)+(5*2)+(4*3)+(3*3)+(2*6)+(1*2)=155
155 % 10 = 5
So 762233-62-5 is a valid CAS Registry Number.
762233-62-5Relevant academic research and scientific papers
AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 35, (2008/06/13)
The present invention is directed to novel substituted aminocyclohexanes of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
-
Page/Page column 18, (2008/06/13)
The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
